Piedmont Cancer Institute, P.C. — Atlanta, Georgia

Piedmont Cancer Institute, P.C. is a clinical research site located in Atlanta, Georgia, United States 30318.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

Piedmont Cancer Institute, P.C. has participated in 3 clinical trials.

Therapeutic areas: HER-2 Positive Breast Cancer, Metastatic Neoplasm, Metastatic Castration Resistant Prostate Cancer.

Sponsors: MacroGenics, pharmaand GmbH, Sumitomo Pharma America, Inc..

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Piedmont Cancer Institute, P.C.?

Piedmont Cancer Institute, P.C. has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Piedmont Cancer Institute, P.C. conducted?

Piedmont Cancer Institute, P.C. has 3 clinical trials on record. Their work covers HER-2 Positive Breast Cancer, Metastatic Neoplasm, Metastatic Castration Resistant Prostate Cancer.

Is Piedmont Cancer Institute, P.C. accredited by Crixeo Health?

Piedmont Cancer Institute, P.C. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Piedmont Cancer Institute, P.C.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.